siltuximab 100 MG Injection [Sylvant]

RxCUI: 1658135
RxNorm name: siltuximab 100 MG Injection [Sylvant]
Display name: siltuximab 100 MG Injection [Sylvant]
Full name: siltuximab 100 MG Injection [Sylvant]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125496	Sylvant	siltuximab	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sylvant	SILTUXIMAB	Recordati Rare Diseases, Inc.	8d663642-f52e-49c0-a023-2da083fdfc0b	2024-08-27	Warnings, Adverse reactions	Exact identifier rxcui: 1658135

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
8d663642-f52e-49c0-a023-2da083fdfc0b	siltuximab 100 MG Injection [Sylvant]	SBD	7	These highlights do not include all the information needed to use SYLVANT ® safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 2014	20240827
8d663642-f52e-49c0-a023-2da083fdfc0b	Sylvant 100 MG Injection	SY	7	These highlights do not include all the information needed to use SYLVANT ® safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 2014	20240827
8d663642-f52e-49c0-a023-2da083fdfc0b	Sylvant 100 MG Injection	PSN	7	These highlights do not include all the information needed to use SYLVANT ® safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 2014	20240827